mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.057 |
0.2 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.2 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |